| Bienvenido a CICESE
Datos Personales
Nombre:
Fournier Pierrick Gerard Jean
Categoría:
INVESTIGADOR TITULAR
SNI:
INVESTIGADOR I
Departamento:
DEPARTAMENTO DE INNOVACIÓN BIOMÉDICA
División:
DIVISIÓN BIOLOGÍA EXPERIMENTAL Y APLICADA
Correo:
fournier@cicese.mx
Extensión:
27213
Proyectos
Caracterización de las interacciones entre las células cancerosas y normales para la prevención y el tratamiento del cáncer y la metástasis
Laboratorios
Investigación y tratamiento en cáncer y patologías óseas
Hay 33 publicaciones.

Año

Autores / Publicación

2022

Arellano Rodríguez, D. L., Juárez Camacho, P., Verdugo Meza, A. A., Almeida Luna, P. S., Corral Avila, J. A., Drescher, F. C. L., Olvera Rodriguez, F., Jiménez Flores, S. M., Elzey, B. D., Guise, T., & Fournier, P. G. J. (2022). Bone microenvironment-suppressed T cells increase osteoclast formation and osteolytic bone metastases in mice. JOURNAL OF BONE AND MINERAL RESEARCH, 37(8), 1446-1463. doi: 10.1002/jbmr.4615. (ID: 27790)

2020

Fournier, P. G. J., Fajardo Yamamoto, L. M., & Juárez Camacho, P. (2020). TGF-ß and BMP Signaling Pathways in Cancer and Bone: In Sickness and in Health. In Mone Zaidi (Eds.), Encyclopedia of Bone Biology (pp. 281-293). Academic Press. (ID: 26081)

2020

Mendoza Reinoso, V., McCauley, L., & Fournier, P. G. J. (2020). Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers, 12(4), e1014. doi: 10.3390/cancers12041014. (ID: 26039)

2020

Drescher, F. C. L., Juárez Camacho, P., Arellano Rodríguez, D. L., Serafín Higuera, N., Olvera Rodriguez, F., Jiménez Flores, S. M., Licea Navarro, A. F., & Fournier, P. G. J. (2020). TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases. Cancers, 12(4), e868. doi: 10.3390/cancers12040868. (ID: 26040)

2020

Núñez Rivera, A., Fournier, P. G. J., Arellano Rodríguez, D. L., rodriguez hernández, a. g., Vazquez Duhalt, R., & Cadena Nava, R. D. (2020). Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes. Beilstein Journal of Nanotechnology, 11, 372-382. doi: 10.3762/bjnano.11.28. (ID: 25972)

2019

Vazquez Muñoz, R., Meza Villezcas, A., Fournier, P. G. J., Soria Castro, E., Juárez Moreno, K., Gallego Hernández, A., Bogdanchikova, N., Vázquez Duhalt, R., & Huerta Saquero, A. (2019). Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane. PLoS ONE, 14(11), e0224904. doi: 10.1371/journal.pone.0224904. (ID: 25181)

2018

Millán Gómez, D. V., Dueñas Espinoza, S., Muñoz, P. L. A., Camacho Villegas, T. A., Elosua, C., Cabanillas Bernal, O., Escalante, T., Almudena, P., Abia, D., Drescher, F. C. L., Fournier, P. G. J., Ramos Ibarra, M. A., Mares, R. E., Paniagua Solís, J. F., Mata González, M. T., Gonzalez Canudas, J., Hoffman, R., Licea Navarro, A. F., & Sánchez Campos, L. N. (2018). In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization. Oncotarget, 9(46), 28016-28029. doi: 10.18632/oncotarget.25549. (ID: 23951)

2018

Jain, A., Fournier, P. G. J., Mendoza, v., Sengar, P., Guerra Olvera, F. M., Iñiguez Pacheco, J. E., Kretzschmar, T. G., Hirata Flores, G. A., & Juárez Camacho, P. (2018). Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging. JOURNAL OF NANOBIOTECHNOLOGY, 16(1), 26. doi: 10.1186/s12951-018-0359-9©. (ID: 23640)

2018

Sengar, P., Juárez Camacho, P., Verdugo Meza, A. A., Arellano Rodríguez, D. L., Jain, A., Chauhan, K., Hirata Flores, G. A., & Fournier, P. G. J. (2018). Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. JOURNAL OF NANOBIOTECHNOLOGY, 16, 19. doi: 10.1186/s12951-018-0344-3. (ID: 23609)

2017

Juárez Camacho, P., Fournier, P. G. J., Mohammad, K., McKenna, R., Davis, H., Peng, X., Niewolna, M., Mauviel, A., Chirgwin, J., & Guise, T. (2017). Halofuginone inhibits TGF-ß/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. Oncotarget, 8(49), 86447-86462. doi: 10.18632/oncotarget.21200. (ID: 22561)

2017

Trivedi, T., Zheng, Y., Fournier, P. G. J., Murthy, S., John, S., Schillo, S., Dunstan, C. R., Mohammad, K., Zhou, H., Seibel, M. J., & Guise, T. (2017). The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. Oncotarget, 8(16), 26687-26701. doi: 10.18632/oncotarget.15803. (ID: 22456)

2015

Suvannasankha, A., Tompkins, D., Edwards, D., Petyaykina, K., Crean, C., Fournier, P. G. J., Parker, J., Sandusky, G., Ichikawa, S., Imel, E., & Chirgwin, J. (2015). FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget, 6(23), 19647-19660. doi: 10.18632/oncotarget.3794. (ID: 19183) (E)

2015

Stayrook, K., Mack, J., Cerabona, D., Edwards, D., Bui, H., Niewolna, M., Fournier, P. G. J., Mohammad, K., Waning, D., & Guise, T. (2015). TGFß-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis. BoneKEy Reports, 4(719), 13. doi: 10.1038/bonekey.2015.88. (ID: 19419) (E)

2015

Fournier, P. G. J., Juárez Camacho, P., Jiang, G., Clines, G., Niewolna, M., Kim, H. S., Walton, H., Peng, X., Liu, Y., Mohammad, K., Wells, C., Chirgwin, J., & Guise, T. (2015). The TGF-ß Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. CANCER CELL, 27(6), 809-821. doi: 10.1016/j.ccell.2015.04.009. (ID: 19179) (E)

2014

Fournier, P. G. J., Juárez Camacho, P., & Guise, T. (2014). Tumor-bone interactions: there is no place like bone. In Dominique Heymann (Eds.), Bone Cancer - Primary Bone Cancers and Bone Metastases (2nd ed.). Academic Press. (ID: 18148) (E)